Since we found some evidence for an effect of age at first birth on ER-negative breast cancer risk with relatively strong instruments, we investigated the effects of age at first birth on HER2-enriched and triple-negative breast cancer risk in a similar manner as in relation to overall, ER-positive, and ER-negative breast cancer risk. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.